Tag: veterinary anti infectives market statistics

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Veterinary Anti-infectives Market Poised To Hit $9.53 Billion By 2030 With A 9.7% CAGR

The veterinary anti-infectives market has demonstrated significant expansion in recent years. It is forecast to grow from $6.02 billion in 2025 to $6.59 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.6%. The market’s past growth can be attributed to several factors including the rising prevalence of livestock diseases, an increasing companion animal population, a traditional reliance on antibiotics, enhanced veterinary awareness, and the expansion of veterinary clinics, especially in the Asia-Pacific region.

The veterinary anti-infectives market size is expected to show significant expansion in the upcoming years. It is projected to reach $9.53 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This growth in the forecast period is driven by factors such as an escalating demand for precision veterinary medicines, the increasing adoption of antiviral and antifungal agents, a greater emphasis on preventive healthcare, the expansion of veterinary hospitals and pharmacies, and the development of immune modulators and advanced disinfectants. Dominant trends during the forecast period include the rising application of antibiotics and antimicrobial agents, a greater uptake of vaccines and antiviral medications, an enhanced awareness of animal disease prevention, the enlargement of the companion animal healthcare market, and an increasing need for topical and systemic antifungal treatments.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=7802&type=smp&name=Veterinary%20Anti-infectives%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Anti-infectives Market Industry Drivers: What’s Behind The Revenue Growth?

A rise in pet ownership is projected to drive the expansion of the veterinary anti-infectives market in the future. Pet ownership denotes having a dog, cat, or other domestic animal within the household. The adoption of pets is growing as more young individuals regard them as family members, while some owners acquire them for their companionship, faithfulness, and to combat loneliness. Veterinary anti-infectives aid pet owners by preventing and addressing infections in their animals, thereby safeguarding their health and lessening the likelihood of sickness for both pets and humans. For example, in 2023, data from the Shelter Animals Count, a US-based non-governmental organization, revealed that 177,000 more dogs and cats were present in the country’s animal shelter network compared to the corresponding period in 2022. Consequently, the surge in pet ownership is fueling the demand within the veterinary anti-infectives market.

Veterinary Anti-infectives Market Segment Analysis Spotlighting Growth Areas

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Other Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

#Veterinary Anti-infectives Market Growth Trends: What’s Shaping The Future Outlook?

Leading companies in the veterinary anti-infectives market are deploying sophisticated technologies to maintain their standing. These advanced technologies encompass inventive methods and instruments that enhance the prevention, diagnosis, and treatment of animal infections, thereby improving both efficacy and safety. For example, in May 2025, Amazon.com Inc., a US-based e-commerce and pharmacy services provider, introduced an expanded selection of pet prescription medications. This initiative, forged in collaboration with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based prominent veterinary technology and pharmacy platform, empowers customers to order veterinarian-approved anti-infective and other prescriptions online, typically delivering them within two to six days, and simplifies refill approvals through digital checkout integration and veterinarian verification. While this innovation extends reach and boosts client engagement, it might necessitate meticulous integration into clinical workflows and adherence to regulatory standards.

Veterinary Anti-infectives Market Key Participants And Competitive Landscape

Major companies operating in the veterinary anti-infectives market are Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

View The Full Veterinary Anti-infectives Market Report:

https://thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Anti-infectives Market Geographic Analysis: Where Is Demand Accelerating Fastest?

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Veterinary Anti-infectives Market Poised To Hit $9.53 Billion By 2030 With A 9.7% CAGR#_x000D_

The veterinary anti-infectives market has demonstrated significant expansion in recent years. It is forecast to grow from $6.02 billion in 2025 to $6.59 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.6%. The market’s past growth can be attributed to several factors including the rising prevalence of livestock diseases, an increasing companion animal population, a traditional reliance on antibiotics, enhanced veterinary awareness, and the expansion of veterinary clinics, especially in the Asia-Pacific region._x000D_

_x000D_

The veterinary anti-infectives market size is expected to show significant expansion in the upcoming years. It is projected to reach $9.53 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This growth in the forecast period is driven by factors such as an escalating demand for precision veterinary medicines, the increasing adoption of antiviral and antifungal agents, a greater emphasis on preventive healthcare, the expansion of veterinary hospitals and pharmacies, and the development of immune modulators and advanced disinfectants. Dominant trends during the forecast period include the rising application of antibiotics and antimicrobial agents, a greater uptake of vaccines and antiviral medications, an enhanced awareness of animal disease prevention, the enlargement of the companion animal healthcare market, and an increasing need for topical and systemic antifungal treatments._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=7802&type=smp&name=Veterinary%20Anti-infectives%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Anti-infectives Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_

A rise in pet ownership is projected to drive the expansion of the veterinary anti-infectives market in the future. Pet ownership denotes having a dog, cat, or other domestic animal within the household. The adoption of pets is growing as more young individuals regard them as family members, while some owners acquire them for their companionship, faithfulness, and to combat loneliness. Veterinary anti-infectives aid pet owners by preventing and addressing infections in their animals, thereby safeguarding their health and lessening the likelihood of sickness for both pets and humans. For example, in 2023, data from the Shelter Animals Count, a US-based non-governmental organization, revealed that 177,000 more dogs and cats were present in the country’s animal shelter network compared to the corresponding period in 2022. Consequently, the surge in pet ownership is fueling the demand within the veterinary anti-infectives market._x000D_

_x000D_

#Veterinary Anti-infectives Market Segment Analysis Spotlighting Growth Areas#_x000D_

The veterinary anti-infectives market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes_x000D_

2) By Species Type: Livestock Animals, Companion Animals_x000D_

3) By Mode Of Administration: Oral, Parenteral, Topical_x000D_

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Other Distribution Channels_x000D_

_x000D_

Subsegments:_x000D_

1) By Antimicrobial Agents: Antibiotics, Antiseptics _x000D_

2) By Antiviral Agents: Vaccines, Antiviral Medications _x000D_

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals _x000D_

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants_x000D_

_x000D_

#Veterinary Anti-infectives Market Growth Trends: What’s Shaping The Future Outlook?_x000D_

Leading companies in the veterinary anti-infectives market are deploying sophisticated technologies to maintain their standing. These advanced technologies encompass inventive methods and instruments that enhance the prevention, diagnosis, and treatment of animal infections, thereby improving both efficacy and safety. For example, in May 2025, Amazon.com Inc., a US-based e-commerce and pharmacy services provider, introduced an expanded selection of pet prescription medications. This initiative, forged in collaboration with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based prominent veterinary technology and pharmacy platform, empowers customers to order veterinarian-approved anti-infective and other prescriptions online, typically delivering them within two to six days, and simplifies refill approvals through digital checkout integration and veterinarian verification. While this innovation extends reach and boosts client engagement, it might necessitate meticulous integration into clinical workflows and adherence to regulatory standards._x000D_

_x000D_

#Veterinary Anti-infectives Market Key Participants And Competitive Landscape#_x000D_

Major companies operating in the veterinary anti-infectives market are Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A. _x000D_

_x000D_

#View The Full Veterinary Anti-infectives Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Anti-infectives Market Geographic Analysis: Where Is Demand Accelerating Fastest?#_x000D_

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Veterinary Anti-infectives Market Compare Between 2026 And 2030?

The veterinary anti-infectives market size has experienced strong growth in recent years. It is anticipated to expand from $6.02 billion in 2025 to $6.59 billion in 2026, at a compound annual growth rate (CAGR) of 9.6%. The growth observed historically can be attributed to the rising prevalence of livestock diseases, a growing companion animal population, traditional reliance on antibiotics, increasing veterinary awareness, and the expansion of veterinary clinics in asia-pacific.

The market size for veterinary anti-infectives is projected to experience substantial expansion over the upcoming years. This market is predicted to reach $9.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this anticipated growth include an increasing demand for precision veterinary medicines, the growing acceptance of antiviral and antifungal agents, an enhanced emphasis on preventive healthcare, the expansion of veterinary hospitals and pharmacies, and advancements in immune modulators and sophisticated disinfectants. Key trends identified for the forecast period encompass a greater utilization of antibiotics and antimicrobial agents, an increase in the uptake of vaccines and antiviral medications, a heightened awareness regarding animal disease prevention, the growth of the companion animal healthcare market, and an escalating demand for both topical and systemic antifungal treatments.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

What Influential Factors Are Boosting The Veterinary Anti-infectives Market Demand?

An increase in pet ownership is expected to propel the growth of the veterinary anti-infectives market going forward. Pet ownership refers to owning a dog, cat, or other domestic pet at home. Pets are being adopted as increasing number of the young population are considering them as part of their family, some owners are adopting them for their compassion, loyalty and the to prevent loneliness. Veterinary anti-infectives help pet ownership by preventing and treating infections in pets, ensuring their health and reducing the risk of illness for both animals and owners. For instance, in 2023, according to the Shelter Animals Count, a US-based non-governmental organization, 177,000 additional dogs and cats were in the animal sheltering system nationwide compared to the same time in 2022. Therefore, an increase in pet ownership is driving the demand for veterinary anti-infectives market.

Which Segment Groups Define The Veterinary Anti-infectives Market Landscape?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Other Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

What Trends Are Affecting The Growth Of The Veterinary Anti-infectives Market?

Major companies operating in the market are using advanced technologies to sustain their position in the veterinary anti-infectives market. Advanced technologies refer to innovative methods and tools that improve the prevention, diagnosis, and treatment of infections in animals, enhancing effectiveness and safety. For instance, in May 2025, Amazon.com Inc., a US based e commerce and pharmacy services provider, launched expanded pet prescription medication offerings in partnership with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based leading veterinary technology and pharmacy platform, that allow customers to order veterinarian approved anti infective and other prescriptions online, provide delivery typically within two to six days, and simplify refill approvals through digital checkout integration and veterinarian verification. This innovation broadens access and enhances client engagement but may require careful integration with clinical workflows and adherence to regulatory standards.

Who Are The Firms Contributing To The Veterinary Anti-infectives Market Ecosystem?

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary Anti-infectives Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Which Region Accounts For The Highest Share Of The Veterinary Anti-infectives Market?

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Veterinary Anti-infectives Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Antiviral Combination Therapy Market During The Forecast Period 2026–2030?

The veterinary anti-infectives market has demonstrated substantial growth in recent years. It is anticipated to expand from $6.02 billion in 2025 to $6.59 billion in 2026, at a compound annual growth rate (CAGR) of 9.6%. This historical expansion can be attributed to several factors, including the increasing occurrence of livestock diseases, a rising companion animal population, the long-standing reliance on antibiotics, greater veterinary awareness, and the proliferation of veterinary clinics, particularly in the Asia-Pacific region.

The veterinary anti-infectives market is projected for significant expansion over the coming years, with its value expected to reach $9.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. This growth in the forecast period is fueled by factors such as a rising demand for precision veterinary medicines, the increasing adoption of antiviral and antifungal agents, a heightened focus on preventive healthcare, the expansion of veterinary hospitals and pharmacies, and the development of immune modulators and advanced disinfectants. Noteworthy trends during this time include the increasing use of antibiotics and antimicrobial agents, the rising adoption of vaccines and antiviral medications, a growing awareness of animal disease prevention, the expansion of the companion animal healthcare market, and a surging demand for topical and systemic antifungal treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Which Economic Or Industry Drivers Are Impacting The Antiviral Combination Therapy Market?

The growth of the veterinary anti-infectives market is projected to be propelled by an escalation in pet ownership. Pet ownership encompasses having a dog, cat, or another domestic animal at home. The increasing adoption of pets stems from a rising proportion of the young population regarding them as family members, with some owners also embracing them for their companionship, faithfulness, and as a means to counteract loneliness. Veterinary anti-infectives play a vital role in supporting pet ownership by effectively preventing and managing infections in animals, which ensures their health and minimizes the likelihood of illness for both pets and their owners. Illustratively, in 2023, figures from Shelter Animals Count, a US-based non-governmental organization, revealed that the animal sheltering system nationwide accommodated an additional 177,000 dogs and cats compared to the same timeframe in 2022. Thus, the expansion of pet ownership is fueling the demand for the veterinary anti-infectives market.

What Market Segments Are Evaluated Within The Antiviral Combination Therapy Market?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Other Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

What Industry Trends Are Redefining The Veterinary Anti-infectives Market?

Leading companies within the veterinary anti-infectives market are utilizing sophisticated technologies to sustain their competitive standing. These advanced technologies refer to innovative methods and tools that improve the prevention, diagnosis, and treatment of infections in animals, enhancing their effectiveness and safety. For instance, in May 2025, Amazon.com Inc., a US-based e-commerce and pharmacy services provider, launched expanded pet prescription medication offerings in partnership with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based leading veterinary technology and pharmacy platform. This allows customers to order veterinarian-approved anti-infective and other prescriptions online, provides delivery typically within two to six days, and simplifies refill approvals through digital checkout integration and veterinarian verification. This innovation broadens access and enhances client engagement but may require careful integration with clinical workflows and adherence to regulatory standards.

Who Are The Top Market Participants Influencing The Antiviral Combination Therapy Market?

Major companies operating in the veterinary anti-infectives market are Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Read the full veterinary anti-infectives market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

What Are The Top-Performing Regions Within The Antiviral Combination Therapy Market?

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Antiviral Combination Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Browse Through More Reports Similar to the Global Veterinary Anti-infectives Market 2026, By The Business Research Company

Animal Antibiotics And Antimicrobials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the fin field-effect transistor (finfet) 3d transistors market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Veterinary Anti-infectives Market reach by 2030 starting from 2026 levels?

The veterinary anti-infectives market size has experienced robust expansion in recent years. Its valuation is projected to increase from $6.02 billion in 2025 to $6.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.6%. Historically, this growth has been driven by factors such as the rising prevalence of livestock diseases, a growing companion animal population, the traditional reliance on antibiotics, increasing veterinary awareness, and the expansion of veterinary clinics in asia-pacific.

The veterinary anti-infectives market size is anticipated to experience robust growth in the upcoming years. It is forecast to reach $9.53 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. The expansion over the forecast period is attributed to the rising demand for precision veterinary medicines, increasing adoption of antiviral and antifungal agents, a greater focus on preventive healthcare, the expansion of veterinary hospitals and pharmacies, and the development of immune modulators and advanced disinfectants. Key trends during this period include a growing use of antibiotics and antimicrobial agents, rising adoption of vaccines and antiviral medications, increasing awareness of animal disease prevention, the expansion of the companion animal healthcare market, and a heightened demand for topical and systemic antifungal treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Which Drivers Are Influencing Long-Term Growth In The Veterinary Anti-infectives Market?

The veterinary anti-infectives market is anticipated to expand due to a rise in pet ownership. Pet ownership involves keeping a dog, cat, or other domesticated animal in one’s home. The younger generation is increasingly welcoming pets into their families, while some individuals choose to adopt them for their companionship, faithfulness, and to combat solitude. These veterinary anti-infectives play a crucial role in pet care by preventing and treating various infections in animals, thus safeguarding their well-being and mitigating health risks for both the pets and their human companions. A supporting example is from 2023, when the Shelter Animals Count, a US-based non-governmental organization, reported an additional 177,000 dogs and cats within the nationwide animal sheltering system compared to the same period in 2022. Consequently, the rising trend in pet ownership is fueling the demand for the veterinary anti-infectives market.

Which Segments Are Driving Activity In The Veterinary Anti-infectives Market?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Other Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Which Trends Are Expected To Influence The Veterinary Anti-infectives Market In The Upcoming Years?

Major companies operating in the veterinary anti-infectives market are leveraging advanced technologies to maintain their competitive position. These advanced technologies encompass innovative methods and tools designed to improve the prevention, diagnosis, and treatment of infections in animals, enhancing their effectiveness and safety. As an example, in May 2025, Amazon.com Inc., a US-based e-commerce and pharmacy services provider, rolled out expanded pet prescription medication offerings in partnership with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based leading veterinary technology and pharmacy platform. This enables customers to order veterinarian-approved anti-infective and other prescriptions online, with delivery typically within two to six days, and streamlines refill approvals through digital checkout integration and veterinarian verification. This innovation broadens access and boosts client engagement but may necessitate careful integration with clinical workflows and adherence to regulatory standards.

Which Key Players Are Driving Competition In The Veterinary Anti-infectives Market?

Major companies operating in the veterinary anti-infectives market are Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Which Region Is Projected To Lead The Veterinary Anti-infectives Market During The Forecast Period?

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Anti-infectives Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Browse Through More Reports Similar to the Global Veterinary Anti-infectives Market 2026, By The Business Research Company

Animal Antibiotics And Antimicrobials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary anti-infectives market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Veterinary Anti-infectives Market And What Value Is Projected For 2029?

The veterinary anti-infectives sector has experienced significant expansion lately, with its market valuation projected to climb from $5.54 billion in 2024 to $6.02 billion by 2025, reflecting an 8.6% compound annual growth rate over that timeframe; this robust upward trend throughout the historical period is underpinned by several factors, including a larger population of pets, the rising incidence of various infectious ailments, strides made in veterinary medical science, heightened public understanding of animal health, and supportive governmental programs.

Projected for considerable expansion, the global market for veterinary anti-infectives is anticipated to reach a valuation of $8.69 billion by the year 2029, reflecting a sustained compound annual growth rate (CAGR) of 9.6% throughout the planning horizon; this upward trajectory is fueled by several key factors, such as the persistent rise in the number of companion animals, the emergence of diseases transmissible between animals and humans, the widening scope of international pet commerce, and the escalating spending dedicated to animal medical care, while notable shifts influencing this market include progress in technology, greater uptake of biologic treatments, the incorporation of remote consultation services into veterinary practice, a heightened interest in plant-derived and herbal remedies, the broadening reach of online sales for animal health drugs, and the formation of strategic alliances across the industry.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

What Factors Are Boosting The Veterinary Anti-infectives Market?

Future expansion within the veterinary anti-infectives sector is anticipated to be driven by a rise in the number of people who own pets, which includes keeping domestic animals like cats or dogs at home. A growing segment of the younger demographic views these animals as integral family members, while others procure them due to feelings of affection, the animals’ devoted nature, or as a defense against solitude. Demonstrating this trend, data from Animal Medicines Australia, an Australian non-profit group, indicated that pet ownership in Australia experienced substantial growth in 2022; the count of pet owners climbed to 28,730.8 that year, a considerable jump from the 39% figure reported in 2021, signifying a notable twenty-four percent escalation and pointing towards a robust pattern of increased pet acquisition and related healthcare expenditure. Consequently, this escalating prevalence of pet ownership directly fuels the need for veterinary anti-infective products.

What Are The Core Segmentation Criteria In The Veterinary Anti-infectives Market?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Which Emerging Trends Are Reshaping The Veterinary Anti-infectives Market Landscape?

A prominent movement within the sphere of veterinary anti-infectives involves the increasing adoption of cutting-edge technological progress, prompting key industry players to leverage sophisticated innovations to secure and enhance their standing. Illustratively, in February of 2022, Elanco Animal Health Incorporated, a US entity specializing in producing medicines and vaccines for companion and farm animals, introduced Increxxa, a recently authorized medication aimed at addressing respiratory illnesses in livestock. Containing tulathromycin as its core component, Increxxa is administered via injection to the animals, where it rapidly concentrates in the infected lung tissue, enabling swift therapeutic effect and a prolonged half-life, thereby affording cattle a greater window to build robustness against disease; this veterinarian-prescribed product utilizes tulathromycin to mitigate the adverse consequences associated with bovine respiratory disease.

Which Players Are Shaping The Competitive Landscape Of The Veterinary Anti-infectivesXX Market?

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

What Regional Trends Are Shaping Growth In The Veterinary Anti-infectives Market?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Browse Through More Reports Similar to the Global Veterinary Anti-infectives Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Veterinary Anti-infectives Industry By The Forecast Year 2029?

The veterinary anti-infectives market size has seen significant growth in recent years. It is anticipated to expand from $5.54 billion in 2024 to $6.02 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.6%. This historical growth can be attributed to increasing pet ownership, the prevalence of infectious diseases, advancements in veterinary medicine, rising awareness, and government initiatives.

The market size for veterinary anti-infectives is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $8.69 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the forecast period include the ongoing increase in pet populations, the emergence of zoonotic diseases, the global expansion of the pet trade, and rising veterinary healthcare spending. Key trends anticipated within the forecast timeframe encompass technological innovations, a greater uptake of biological products, the incorporation of telehealth into veterinary services, a shift towards natural and herbal remedies, the widening reach of e-commerce for veterinary pharmaceuticals, and strategic alliances and joint ventures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

What Are The Main Drivers Boosting The Veterinary Anti-infectives Industry’s Expansion?

The future expansion of the veterinary anti-infectives market is anticipated to be driven by a rise in pet ownership. This trend of pet ownership involves individuals keeping dogs, cats, or other domesticated animals in their homes. A growing segment of the younger population is integrating pets into their families, while others embrace them for their inherent compassion, loyalty, and as a means to combat loneliness. For example, data from 2022, released by Animal Medicines Australia, an Australia-based non-governmental organization, showed a substantial increase in pet ownership within Australia. The total number of pet owners reached 28,730.8 in 2022, which was an increase from 39% recorded in 2021. This specific figure signifies a 24% rise, underscoring a robust upward trajectory in both pet adoption and associated care expenditures. This escalation in pet ownership further emphasizes the increasing prominence of pets among Australian households. Consequently, the expanding trend of pet ownership is fueling the demand within the veterinary anti-infectives market.

How Is The Veterinary Anti-infectives Market Segmented?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

What Are The Major Trends Driving The Growth Of The Veterinary Anti-infectives Market?

Technological innovation is a prominent trend gaining considerable attention within the veterinary anti-infectives market. Major businesses operating in this sector are deploying advanced technologies to uphold their standing. As an illustration, in February 2022, Elanco Animal Health Incorporated, a US-based pharmaceutical company focused on medications and immunizations for pets and livestock, introduced Increxxa. This recently approved drug for livestock respiratory disease utilizes tulathromycin as its main ingredient, administered to livestock through injection. Increxxa rapidly targets the infection site in the lungs for swift action and boasts a prolonged half-life, affording cattle more time to build a strong defense. This product is intended for veterinary application, and tulathromycin, the active component in Increxxa, aids in diminishing the detrimental effects of bovine respiratory disease.

Which Global Market Leaders Are Shaping The Future Of The Veterinary Anti-infectives Sector?

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Veterinary Anti-infectives Market?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Veterinary Anti-infectives Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Browse Through More Reports Similar to the Global Veterinary Anti-infectives Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Veterinary Anti-infectives Market From 2025 To 2029?

The market size for veterinary anti-infectives has been experiencing robust growth in the past few years. It’s projected to expand from $5.54 billion in 2024 to $6.02 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.6%. This growth over the historical period is linked to factors such as increased pet ownership, a higher incidence of infectious diseases, advancements in veterinary medicine, growing awareness, and government policies.

In the coming years, the veterinary anti-infectives market size is anticipated to witness robust growth. The growth is projected to reach a market value of $8.69 billion by 2029, with a compound annual growth rate (CAGR) of 9.6%. Various contributing factors to this projected growth during the forecast period include an expanding pet population, arising zoonotic diseases, the global pet trade market, and an increase in the expenditure of veterinary healthcare. Key trends predicted for the forecast timeframe include advancements in technology, the growing preference for biologicals, the addition of telehealth in veterinary services, a shift towards natural and herbal alternatives, the rise of e-commerce within veterinary pharmaceuticals, and a growing trend of collaborations and partnerships.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Which Factors and External Forces Are Driving Demand in the Veterinary Anti-infectives Market?

The anticipated rise in pet ownership is predicted to fuel the expansion of the veterinary anti-infectives market. Pet ownership, which comprises adoption of dogs, cats, or other domestic pets, is on the rise as an ever-increasing proportion of younger generations consider pets as family members, adopting them out of compassion, for their loyalty and as a remedy against loneliness. For instance, Animal Medicines Australia, a non-governmental organization based in Australia, revealed that pet ownership in the country surged in 2022, with the count of pet owners reaching 28,730.8, up from 39% in 2021, marking a 24% hike. This evidences a robust uptrend in pet adoption and associated care investment. The booming popularity of pets in Australian homes is underpinning the rise in pet ownership. Consequently, this surge in pet ownership is bolstering the demand for the veterinary anti-infectives market.

Which Segments in the Veterinary Anti-infectives Offer the Most Growth?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Veterinary Anti-infectives Market?# Market?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theVeterinary Anti-infectives Market’s Growth?

The veterinary anti-infectives market is witnessing a surge in popularity due to technological advancements. Major industry players, in order to secure their market dominance, are employing cutting-edge techniques. For instance, US-based pharmaceutical entity Elanco Animal Health Incorporated, known for producing medications and vaccines for pets and livestock, introduced a new product in February 2022, dubbed Increxxa. This drug, intended to manage livestock respiratory illness, is delivered by injection, quickly reaching the infection site in the animals’ lungs due to the key ingredient tulathromycin, and offers an extended half-life, thereby giving cattle ample time to build robust defenses. Increxxa, which contains tulathromycin, is formulated particularly for animal application and aids in mitigating the detrimental impacts of bovine respiratory disease.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

What Are the Key Elements That Define the Veterinary Anti-infectives Market?

The term veterinary anti-infective refers to a broad category where animals are cared for by providing both illness prevention and cure approaches. They are used in veterinary medicine to ensure the health and well-being of livestock and pets, as well as to manage disease outbreaks in animal populations.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7802

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Veterinary Anti-infectives Market Size Changed, over the years?

In recent times, the veterinary anti-infectives market has seen significant growth. The market’s size is predicted to increase from $5.54 billion in 2024 to $6.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. This growth observed in the historic period can be credited to factors such as the rise in pet ownership, the prevalence of infectious diseases, advancements in veterinary medicine, heightened awareness, and government initiatives.

How Much Will the Veterinary Anti-infectives Market Be Worth in 2029?

Anticipations show a vigorous expansion in the veterinary anti-infectives market over the coming years, reaching $8.74 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. This predicted growth within the forecast period is due to factors such as the rising pet population, the emergence of zoonotic diseases, an increase in global pet trade, and escalating veterinary healthcare expenses. The anticipated trends for this period include technological progression, elevated usage of biologicals, the inclusion of telehealth in veterinary services, emphasis on organic and herbal alternatives, the growth of e-commerce in veterinary pharmaceuticals, and strategic collaborations and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Which is the Largest Company in the Veterinary Anti-infectives Market?

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

What Are the Main Market Drivers in the Veterinary Anti-infectives Industry?

The veterinary anti-infectives market is anticipated to expand due to an expected rise in pet ownership. This refers to keeping a dog, cat, or any other domesticated pet at home. An influx in people adopting pets is apparent as more of the young generation is starting to consider them as family members. Pets are being taken in due to their loyalty, resilience, and their ability to help alleviate feelings of solitude. To highlight, in 2022, Animal Medicines Australia, a non-governmental organization based in Australia, reported a noticeable increase in pet ownership in Australia. The figures showed a rise to 28,730.8 pet owners in 2022, a substantial improvement from the 39% reported in 2021. This substantial 24% increase points to a robust rising trend in pet adoption and care-related investments. This growth in pet ownership indicates a swelling affinity towards pets in Australian homes, thereby boosting the demand for the veterinary anti-infectives market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

How Is the Veterinary Anti-infectives Market Segments Structured?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

What Strategic Trends Are Transforming the Veterinary Anti-infectives Market?

The growing popularity of technological advancements is a notable trend in the veterinary anti-infectives market. Industry-leading companies are leveraging state-of-the-art technologies to maintain their market stronghold. For instance, in February 2022, Elanco Animal Health Incorporated, a company based in the US that specializes in the production of medications and vaccines for pets and livestock, unveiled Increxxa. This newly approved drug combats livestock respiratory disease. It’s delivered via injection to the livestock and swiftly targets the lungs’ infection point. Its main component – tulathromycin, coupled with its quick action and extended half-life, grants the cattle ample time to build robust defenses. This drug, designed for veterinary purposes, uses its active ingredient, tulathromycin, to mitigate the adverse effects of bovine respiratory disease.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Which Global Regions Offer the Highest Growth in the Veterinary Anti-infectives Market?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7802

This Report Delivers Insight On:

1. How big is the veterinary anti-infectives market, and how is it changing globally?

2. Who are the major companies in the veterinary anti-infectives market, and how are they performing?

3. What are the key opportunities and risks in the veterinary anti-infectives market right now?

4. Which products or customer segments are growing the most in the veterinary anti-infectives market?

5. What factors are helping or slowing down the growth of the veterinary anti-infectives market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the veterinary anti-infectives industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Veterinary Anti-infectives Market From 2025 To 2029?

Over the past few years, the size of the veterinary anti-infectives market has seen substantial growth. It’s expected to rise from $5.54 billion in 2024 to $6.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The historic growth can be traced back to factors including growing pet ownership rates, increased prevalence of infectious diseases, advancements made in veterinary medicine, heightened awareness, and government actions.

The market size of veterinary anti-infectives is slated for significant expansion in the coming years, with a projected growth to $8.74 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 9.7%. The anticipated growth during the forecast period can be credited to factors such as the rise in pet population, the emergence of zoonotic diseases, global pet trade, and an increase in spending on veterinary healthcare. The forecast period will also see major developments such as technological innovations, a surge in the use of biologicals, the incorporation of telehealth into veterinary services, a focus on herbal and natural alternatives, the broadening of e-commerce in veterinary pharmaceuticals, and strategic collaborations and partnerships.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

What are the Fundamental Drivers and Innovations Shaping the Veterinary Anti-infectives Market?

The anticipated rise in pet ownership is set to boost the expansion of the veterinary anti-infectives market. The term pet ownership implies having a dog, cat, or any other domestic animal as a household pet. More and more young individuals are embracing them as family members, and some owners adopt pets due to their devotedness, their compassion, and as a means to mitigate solitude. For example, Animal Medicines Australia, a non-governmental organization based in Australia, reported a substantial rise in pet ownership in 2022 with the number of pet owners hitting 28,730.8 that year, a jump from 39% in 2021. This is a 24% increase and points to a robust ascending trend in pet adoption and care spending. The upswing in pet ownership emphasizes the increasing prominence of pets in Australian homes, thereby pushing the demand for the veterinary anti-infectives market.

How Is the Veterinary Anti-infectives Market Segmented?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Which Regions Are Driving the Next Phase of the Veterinary Anti-infectives Market Growth?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Veterinary Anti-infectives Market?

Advancements in technology are increasingly becoming a significant trend within the veterinary anti-infectives market. Many top-notch companies in the market are leveraging cutting-edge technologies to maintain their dominance in this industry. For instance, Elanco Animal Health Incorporated, a U.S.-based producer of pharmaceuticals and vaccinations for pets and livestock, introduced Increxxa in February 2022. This FDA-approved medication for livestock respiratory disease contains tulathromycin as its main ingredient and is administered to the livestock through an injection that swiftly targets the infection in the lungs, facilitating quick action and extended half-life, thus giving cattle ample time to build a strong defense mechanism. Increxxa, specially designed for veterinary application, works by mitigating the harmful impacts of bovine respiratory disease.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

How Is the Veterinary Anti-infectives Market Defined and What Are Its Core Parameters?

The term veterinary anti-infective refers to a broad category where animals are cared for by providing both illness prevention and cure approaches. They are used in veterinary medicine to ensure the health and well-being of livestock and pets, as well as to manage disease outbreaks in animal populations.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7802

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model